[email protected]

Tag: Taiwan

Tag Archives: Taiwan

02Jan/24

Innovative Smart Sports and Digital Health Tech From ITRI Debut at CES 2024

January 2, 2024InnovationConsumer Electronics Show, Industrial Technology Research Institute, Las Vegas, LVCC, Mandalay, Mandalay Bay, Taiwanadmin

The Industrial Technology Research Institute (ITRI), Taiwan’s largest and one of the world’s leading high-tech applied research institutions, today announced the introduction of smart sports and digital health innovations at CES 2024 booth 9255, North Hall, LVCC, and its event website. ITRI will also exhibit its smart sports innovations at CES Unveiled Las Vegas booth 226, Shoreline Exhibit Hall, Mandalay Bay Convention Center. Continue reading

2024: The year of democratic elections

January 2, 2024PoliticsAlgeria, Artificial intelligence, Bangladesh, Belgium, Brazil, Confidence tricks, Deception, Deepfake, Disinformation, Fact-checking, Fake news, Finland, Ghana, Hasina, Iceland, India, Indonesia, Internet manipulation and propaganda, Jair Bolsonaro, Liechtenstein, Lying, Media manipulation, Mexico, Misinformation, Pakistan, Propaganda techniques, Senegal, Social media, South Africa, Taiwan, United Kingdom, United Statesadmin

Jan. 2, 2024 /Politics/ — 2024 is shaping up to be a bumper year for elections! Here are some noteworthy examples beyond the UK and USA: Continue reading →

08Sep/23

TIME Reveals Inaugural TIME100 AI List of the World’s Most Influential People in Artificial Intelligence

September 8, 2023InnovationAbeba Birhane, ai group, Aidan Gomez, Alondra Nelson, Amini, Andrew Hopkins, Anna Eshoo, Artificial general intelligence, Artificial intelligence, Audrey Tang, Ayanna Howard, Charlie Brooker, Computational neuroscience, Daniela Amodei, Deborah Raji, DeepMind Lila Ibrahim, DeepMind Shane Legg, Demis Hassabis, Emily Alwell, Emily M. Bender, Eric Schmidt, Ethics of artificial intelligence, exscientia, Fei-Fei Li, Fellows of the Royal Society, Geoffrey Hinton, Google DeepMind, Greg Brockman, Grimes, Holly Herndon, Ian Hogarth, Ilya Sutskever, Inioluwa Deborah Raji, Intel, Jack Clark, Jessica Sibley, Joy Buolamwini, Kate Crawford, Kate Kallot, Kelly McKernan, Linda Dounia Rebeiz, Margaret Mitchell, Max Tegmark, Nancy Xu, Neil Jamieson, New York, Noam Shazeer, Omar Al Olama, OpenAI, Pelonomi Moiloa, Philosophy of artificial intelligence, Raquel Urtasan, Richard Mathenge, Rootport, Sam Altman, Sam Jacobs, Sandra Rivera, Shane Legg, Sneha Revanur, Sougwen Chung, Taiwan, Taskforce Ian Hogarth, Ted Chiang, Ted Lieu, Tegmark, Timnit Gebru, United Arab Emirates, United Kingdom, United States, Yi Zeng, Yoshua Bengioadmin

NEW YORK, Sept. 7, 2023 /PRNewswire/ — Today, TIME reveals the inaugural TIME100 AI, a new list highlighting the 100 most influential people in artificial intelligence.

The 2023 TIME100 AI issue features a worldwide cover with illustrations by Neil Jamieson for TIME, featuring 28 list-makers including Sam Altman of OpenAI, Dario and Daniela Amodei of Anthropic, Demis Hassabis of Google DeepMind, and more from the new list. Continue reading →

13Mar/23

Pfizer Invests $43 Billion to Battle Cancer

March 13, 2023ReasearchAlbert Bourla, Antibody-drug conjugate, Antineoplastic drugs, Articles, ASTELLAS, Astellas Pharma, BOTHELL, brentuximab vedotin, Canada, Centerview Partners, Centerview Partners LLC, China, Chris Boshoff, David Caouette, David Epstein, Douglas, Genmab, Guggenheim Securities LLC, Health, Investment banks, Investor Call Details Pfizer Inc., Japan, Life sciences, Macau, Merck, New York, Pfizer, Pfizer Inc., Pharmaceutical industry, Sanofi S.A., SeaGen, Seagen Inc., Seattle, SULLIVAN & CROMWELL LLP, Switzerland, Taiwan, Takeda, United States, WACHTELL, LIPTON, ROSEN & KATZ, Washington, zai labadmin

Pfizer to acquire Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billion
Proposed combination enhances Pfizer’s position as a leading company in Oncology
Seagen’s medicines, late-stage development programs and pioneering expertise in Antibody-Drug Conjugates (ADCs) strongly complement Pfizer’s Oncology portfolio
Seagen expected to contribute more than $10 billion in risk-adjusted revenues in 2030
Pfizer and Seagen to hold analyst and investor call at 8 a.m. EDT today

NEW YORK & BOTHELL, Wash.–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) and Seagen Inc. (Nasdaq: SGEN) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Seagen, a global biotechnology company that discovers, develops and commercializes transformative cancer medicines, for $229 in cash per Seagen share for a total enterprise value of $43 billion. The Boards of Directors of both companies have unanimously approved the transaction. Continue reading →

26Oct/22

Four scenarios for a world in disorder

October 26, 2022PoliticsAfghanistan, Antony Blinken, Australia, Barack Obama, Beijing, Berlin, Brazil, Cambridge, China, Countries, Creative Commons, David Bach, Donald Trump, G20 nations, Geography of Asia, Germany, Giorgia Meloni, Greece, Hungary, Inflation, Iran, Italy, Jair Bolsonaro, James Bond, Japan, John Hopkins, Member states of the United Nations, Mussolini, North Korea, Paul Volcker, Pierre Olivier Gourinchas, Political economy, Populism, Richard Nixon, Rio Tinto, Roberto Stefan Foa, Russia, Soviet Union, Stagflation, Sweden, Taiwan, Ukraine, Unemployment, United States, Viktor Orban, Vladimir Putin, Washington, World, Xi Jinping, Yaschaadmin

David Bach, International Institute for Management Development (IMD)

Chinese leader Xi Jinping’s recent speech to the Communist Party Congress could be one of the most consequential of the decade. He told the audience – and the world – that his economic growth-crushing zero-COVID policy is here to stay, and that Beijing is more determined than ever to reunify with Taiwan, peacefully if possible and by force if necessary.

Continue reading →